These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6121878)

  • 1. Biochemical and pharmacological activities of zetidoline (DL 308-IT): a new antidopaminergic agent.
    Barone D; Corsico N; Diena A; Restelli A; Glässer A; Rodenghi F
    J Pharm Pharmacol; 1982 Feb; 34(2):129-32. PubMed ID: 6121878
    [No Abstract]   [Full Text] [Related]  

  • 2. Remoxipride, a new potential antipsychotic compound with selective antidopaminergic actions in the rat brain.
    Ogren SO; Hall H; Köhler C; Magnusson O; Lindbom LO; Angeby K; Florvall L
    Eur J Pharmacol; 1984 Jul; 102(3-4):459-74. PubMed ID: 6149133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zetidoline metabolism by rat liver microsomes. Formation of metabolites with potential neuroleptic activity.
    Assandri A; Galliani G; Zerilli L; Tuan G; Tarzia G; Barone D
    Biochem Pharmacol; 1986 May; 35(9):1459-67. PubMed ID: 2871840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zetidoline, a specific dopamine antagonist devoid of antiserotonergic activity in rodent brain.
    Pugnetti P; Barone D; Peruzzi M; Restelli A
    Pharmacol Res Commun; 1985 Dec; 17(12):1141-51. PubMed ID: 2869506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A neuroblastoma clone which has dopamine-sensitive adenylate cyclase but which lacks stereospecific binding sites for the neuroleptic [3H]spiperone.
    Hartley EJ; Spuhler K; Prasad KN; Seeman P
    Brain Res; 1980 May; 190(2):574-7. PubMed ID: 6154511
    [No Abstract]   [Full Text] [Related]  

  • 6. Dopamine receptors in the goldfish retina: 3H-spiroperidol and 3H-domperidone binding; and dopamine-stimulated adenylate cyclase activity.
    Redburn DA; Clement-Cormier Y; Lam DM
    Life Sci; 1980 Jul; 27(1):23-31. PubMed ID: 6105607
    [No Abstract]   [Full Text] [Related]  

  • 7. Characterization of [3H]zetidoline binding to rat striatal membranes.
    Barone D; Assandri A; Galliani G; Glässer A; Tarzia G
    J Pharm Pharmacol; 1985 Mar; 37(3):180-7. PubMed ID: 2858565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zetidoline blocks dopamine autoreceptors in the rat substantia nigra.
    Harris NC; Pinnock RD; Woodruff GN
    Neuropharmacology; 1985 Jan; 24(1):33-6. PubMed ID: 2858831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum.
    Thomas KL; Rose S; Jenner P; Marsden CD
    Biochem Pharmacol; 1992 Jul; 44(1):83-91. PubMed ID: 1321631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The hypotheses of different dopamine receptor mechanisms.
    Costall B; Naylor RJ
    Life Sci; 1981 Jan; 28(3):215-29. PubMed ID: 6111725
    [No Abstract]   [Full Text] [Related]  

  • 11. Synthesis and biological evaluation of p-bromospiperone as potential neuroleptic drug.
    Huang CC; Friedman AM; So R; Simonovic M; Meltzer HY
    J Pharm Sci; 1980 Aug; 69(8):984-6. PubMed ID: 6105200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dopamine D1 receptor: biochemical and behavioral aspects.
    Andersen PH; Nielsen EB
    Adv Exp Med Biol; 1986; 204():73-91. PubMed ID: 2878580
    [No Abstract]   [Full Text] [Related]  

  • 13. Relative activities of SCH 23390 and its analogs in three tests for D1/DA1 dopamine receptor antagonism.
    Barnett A; Ahn HS; Billard W; Gold EH; Kohli JD; Glock D; Goldberg LI
    Eur J Pharmacol; 1986 Sep; 128(3):249-53. PubMed ID: 2878816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. During one year's neuroleptic treatment in rats striatal dopamine receptor blockade decreases but serum prolactin levels remain elevated.
    Dyer RG; Murugaiah K; Theodorou A; Clow A; Jenner P; Marsden CD
    Life Sci; 1981 Jan; 28(2):167-74. PubMed ID: 6114373
    [No Abstract]   [Full Text] [Related]  

  • 15. Functional distinction between DA-stimulated adenylate cyclase and 3H-spiperone binding sites in rat striatum.
    Waddington JL; Cross AJ; Longden A; Owen F; Poulter M
    Eur J Pharmacol; 1979 Oct; 58(3):341-2. PubMed ID: 510367
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of acute administration of zetidoline, a new antidopaminergic drug, on plasma prolactin and aldosterone levels in man.
    Barbieri C; Parodi M; Bruno S; Bertassi F; Benaglia D; Moser P; Meroni R; Dubini A
    Eur J Clin Pharmacol; 1984; 26(1):29-32. PubMed ID: 6143669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in rat striatal dopamine turnover and receptor activity during one years neuroleptic administration.
    Clow A; Theodorou A; Jenner P; Marsden CD
    Eur J Pharmacol; 1980 May; 63(2-3):135-44. PubMed ID: 6103813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dihydrexidine, a novel selective high potency full dopamine D-1 receptor agonist.
    Lovenberg TW; Brewster WK; Mottola DM; Lee RC; Riggs RM; Nichols DE; Lewis MH; Mailman RB
    Eur J Pharmacol; 1989 Jul; 166(1):111-3. PubMed ID: 2572425
    [No Abstract]   [Full Text] [Related]  

  • 19. Dopamine receptor blockade by imidoline and its proposed active conformation.
    Koe BK; Koch SW; Dominy BW
    Eur J Pharmacol; 1980 Nov; 68(2):139-46. PubMed ID: 6110542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolactin-releasing effect of zetidoline, a new neuroleptic agent, in the rat.
    Galliani G; Restelli A; Rosina R; Glässer A
    Pharmacol Res Commun; 1984 Feb; 16(2):117-27. PubMed ID: 6150500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.